Invesaro

Stocks Comparison

Kun Peng International vs Exousia Bio: revenue, profit, margins and growth compared

Kun Peng International brought in $1.4M of revenue in fiscal 2025, Exousia Bio $3.8K in fiscal 2025. Revenue changed by -30.8% at Kun Peng International and -67.4% at Exousia Bio on the year before, so Kun Peng International grew faster. Kun Peng International kept -87.8% of its revenue as net profit, Exousia Bio 1,370.5%.

Side by side, latest fiscal year

KPEALMMY
Fiscal year endedFY2025 (September 30, 2025)FY2025 (May 31, 2025)
Revenue$1.4M$3.8K
Revenue growth-30.8%-67.4%
Net income-$1.3M$51.4K
Net margin-87.8%1,370.5%
Free cash flown/an/a
Free cash flow marginn/an/a
Earnings per share (diluted)-$0.00$0.00
Cash$26.3K$0
Debtn/an/a
Price to earningsn/an/a
Market value$12.8M$750.8K
Dividend yieldn/an/a
Rank by revenue in sector#559 of 605 · Industrials#602 of 605 · Industrials

Over the years

Revenue
KPEA FY2018: $505.1KKPEA FY2019: $83.9KKPEA FY2020: $819.1KKPEA FY2021: $5.6MKPEA FY2022: $7.5MKPEA FY2023: $3.9MKPEA FY2024: $2.1MKPEA FY2025: $1.4MLMMY FY2023: $0LMMY FY2024: $11.5KLMMY FY2025: $3.8KFY18FY19FY20FY21FY22FY23FY24FY25
KPEA $1.4MLMMY $3.8K
Net income
KPEA FY2018: -$548.4KKPEA FY2019: -$206.7KKPEA FY2020: -$208.8KKPEA FY2021: -$1.6MKPEA FY2022: -$1.8MKPEA FY2023: -$2.1MKPEA FY2024: -$2MKPEA FY2025: -$1.3MLMMY FY2023: -$56.4KLMMY FY2024: -$25.8KLMMY FY2025: $51.4KFY18FY19FY20FY21FY22FY23FY24FY25
KPEA -$1.3MLMMY $51.4K
Net margin
KPEA FY2018: -108.6%KPEA FY2019: -246.6%KPEA FY2020: -25.5%KPEA FY2021: -28.9%KPEA FY2022: -24.4%KPEA FY2023: -54.9%KPEA FY2024: -94.8%KPEA FY2025: -87.8%LMMY FY2024: -224.4%LMMY FY2025: 1,370.5%FY18FY19FY20FY21FY22FY23FY24FY25
KPEA -87.8%LMMY 1,370.5%
Revenue growth
KPEA FY2019: -83.4%KPEA FY2020: +876.9%KPEA FY2021: +582.1%KPEA FY2022: +34.4%KPEA FY2023: -47.8%KPEA FY2024: -46.9%KPEA FY2025: -30.8%LMMY FY2025: -67.4%FY19FY20FY21FY22FY23FY24FY25
KPEA -30.8%LMMY -67.4%
Free cash flow
KPEA FY2018: -$665.5KKPEA FY2020: $136.7KKPEA FY2021: $1.9MKPEA FY2022: -$1.7MKPEA FY2024: -$302.6KFY18FY20FY21FY22FY24
KPEA -$302.6KLMMY

Fiscal years as each company reports them; the two may end in different months.

Questions about Kun Peng International and Exousia Bio

Which is bigger by revenue, Kun Peng International or Exousia Bio?

Kun Peng International is bigger by revenue: $1.4M in fiscal 2025, against $3.8K for Exousia Bio in fiscal 2025.

Which keeps more of its revenue as profit, Kun Peng International or Exousia Bio?

Kun Peng International had a net margin of -87.8% in fiscal 2025; Exousia Bio had 1,370.5% in fiscal 2025.

Which grew revenue faster, Kun Peng International or Exousia Bio?

In their latest fiscal years revenue changed by -30.8% at Kun Peng International and -67.4% at Exousia Bio.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies